Stevanato Group S.p.A. (STVN) Research

Stevanato Group S.p.A. is dedicated to engineering, manufacturing, and distributing integrated solutions for the pharmaceutical and healthcare sectors. Its core offerings span a wide array of products, including containment solutions, drug delivery systems, and medical devices, alongside diagnostic and analytical support. The company also produces specialized machinery for tasks such as visual inspection, assembly, packaging, and glass formation. Established in 1949, the company's main operations are situated in Piombino Dese, Italy, functioning as a subsidiary of Stevanato Holding S.R.L.

Market snapshot

Symbol
STVN
Price
$17.54
Day change
+2.81%
Market cap
$4.2B
P/E ratio
29.59x
52-week range
12.89-28
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Next earnings
in 2 months
Analyst price target
$24.75

Peer companies

  • AptarGroup, Inc. (ATR)
  • Avantor, Inc. (AVTR)
  • Axsome Therapeutics, Inc. (AXSM)
  • Bausch + Lomb Corporation (BLCO)
  • BrightSpring Health Services, Inc. Common Stock (BTSG)
  • Chemed Corporation (CHE)
  • Masimo Corporation (MASI)
  • Merit Medical Systems, Inc. (MMSI)

Recent insider activity

  • Santel Luciano — trade (0 shares) on 2026-03-18
  • Magistretti Elisabetta — trade (0 shares) on 2026-03-18
  • Flynn Karen — trade (0 shares) on 2026-03-18
  • FEDERICI WILLIAM J — trade (0 shares) on 2026-03-18
  • FEDERICI WILLIAM J — trade (0 shares) on 2026-03-18

Open Stevanato Group S.p.A. (STVN) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.